Physician profile
Malcolm Roth
NPI 1598775884
$24,754.58
in general payments reported to CMS, 2019-2025
18 companies · $5,042 in 2025
The $5,042 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $448 · 2021: $492 · 2022: $2,779 · 2023: $12K · 2024: $3,438 · 2025: $5,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $3,558 · Travel and Lodging: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,325.00 |
| Food and Beverage | $3,557.69 |
| Travel and Lodging | $542.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $12,950.43 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $6,916.77 | 2020-2023 | |
| Integra Lifesciences Corporation | $2,141.90 | 2019-2025 | Surgimend, Codman Certas, Integra |
| Sientra, INC. | $632.56 | 2019-2021 | |
| Mentor Worldwide LLC | $450.27 | 2019-2022 | |
| Axogen | $407.30 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Becton, Dickinson and Company | $386.67 | 2022 | |
| Kerecis Limited | $209.80 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Davol INC. | $175.03 | 2025 | Phasix Mesh |
| Endo Pharmaceuticals INC. | $139.38 | 2023 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $130.65 | 2025 | |
| Kls-Martin L.P. | $108.19 | 2024 | |
| Mimedx Group, INC. | $25.64 | 2024 | |
| Depuy Synthes Sales INC. | $25.06 | 2019 | |
| Abbvie INC. | $15.91 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $15.58 | 2019 | |
| Stryker Corporation | $14.77 | 2022 | |
| Polarityte, INC. | $8.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.